| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |